Advanced search
Publication Cover
Emerging Microbes & Infections Volume 8, 2019 - Issue 1
Submit an article Journal homepage
1,859
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study

Junjun Jianga Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4905-9348View further author information
ORCID Icon,
Fengxiang Qina Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1459-4826View further author information
ORCID Icon,
Sirun Mengb Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaView further author information
,
Eric J. Nehlc Rollins School of Public Health, Emory University, Atlanta, GA, USAView further author information
,
Jinping Huangb Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaView further author information
,
Yanfen Liub Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaView further author information
,
Jun Zoub Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaView further author information
,
Wenyi Dongb Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaView further author information
,
Jiegang Huanga Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Hui Chena Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Ning Zangd Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Bingyu Lianga Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Chuanyi Ningd Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Yanyan Liaod Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Chaolian Luod Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Huifang Liud Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Xin Liud Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Jian Wanga Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Oulu Zhoua Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of ChinaView further author information
,
Thuy Lee Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA;f Oxford University Clinical Research Unit, Ho Chi Minh City, VietnamView further author information
,
Li Yea Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of China;d Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7688-4867View further author information
ORCID Icon,
Fengyao Wub Fourth People’s Hospital of Nanning, Nanning, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Hao Lianga Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People’s Republic of China;d Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7534-5124View further author information
ORCID Icon show all
Pages 367-376 | Received 22 Oct 2018, Accepted 18 Feb 2019, Published online: 11 Mar 2019

Related Research Data

Penicillium marneffei Infection: An Emerging Disease in Mainland China
Source: Springer Science and Business Media LLC
Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
Source: Taylor & Francis
Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects
Source: American Society for Microbiology
Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004–2011 in Guangzhou, China
Source: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Source: HAL CCSD
Deletion of nudB Causes Increased Susceptibility to Antifolates in Escherichia coli and Salmonella enterica
Source: American Society for Microbiology
Vitamin Biosynthesis as an Antifungal Target
Source: MDPI AG
Trimethoprim-Sulfamethoxazole
Source: Elsevier BV
Review of Human Immunodeficiency Virus Type 1-Related Opportunistic Infections in Sub-Saharan Africa
Source: Oxford University Press (OUP)
Retrospective Analysis of 15 Cases of Penicilliosis marneffei in a Southern China Hospital
Source: Springer Science and Business Media LLC
Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.
Source: Public Library of Science (PLoS)
Effect of co-trimoxazole prophylaxis on morbidity mortality CD4-cell count and viral load in HIV infection in rural Uganda.
Source: Zenodo
Insights into the pathogenicity of Penicillium marneffei
Source: Future Medicine Ltd
Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim–sulfamethoxazole: lessons from an observational cohort study
Source: Springer Science and Business Media LLC
HIV-associated histoplasmosis in French Guiana: recent infection or reactivation?
Source: Ovid Technologies (Wolters Kluwer Health)
Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: A retrospective study
Source: Springer Science and Business Media LLC
Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai.
Source: Ovid Technologies (Wolters Kluwer Health)

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.